Brief: Braxia Scientific CEO Roger Mcintyre To Join Advisory Board Of At-Home Telemedicine Platform KetaMD
09/11/2021 12:24
Nov 9 (Reuters) - Braxia Scientific Corp BRAX.CD :
* BRAXIA SCIENTIFIC CEO DR. ROGER MCINTYRE TO JOIN ADVISORY
BOARD
OF AT-HOME TELEMEDICINE PLATFORM KETAMD
Source text for Eikon: ID:nCNWHfzgGa
Further company coverage: BRAX.CD
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Braxia Scientific
See all newsBrief: Braxia Scientific Reports Q3 2022 Financial Results
Brief: Braxia Scientific CEO Roger Mcintyre To Join Advisory Board Of At-Home Telemedicine Platform KetaMD
Brief: Braxia Scientific To Commence Canada's First Multiple-Dose Psilocybin Trial For Treatment Resistant Depression
Brief: Braxia Scientific Launches Psilocybin-Assisted Clinical Therapy Training Program
Brief: Braxia Scientific Awarded Government Of Canada Funding To Complete First Of Its Kind Ketamine Clinical Trial For Bipolar Depression